Matches in Nanopublications for { ?s ?p "[EGFR intron 1 polymorphism may influence response to treatment with tyrosine kinase inhibitors in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP108376.RArQadwfoPGqYd48iTGI-J4OrR8pO7YeuhqCmKhb8rOdk130_assertion description "[EGFR intron 1 polymorphism may influence response to treatment with tyrosine kinase inhibitors in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108376.RArQadwfoPGqYd48iTGI-J4OrR8pO7YeuhqCmKhb8rOdk130_provenance.
- NP171590.RAUlmLojG3naeDPoWnR_JZbI2Bkr3XvN6Eac1v4qP3gq8130_assertion description "[EGFR intron 1 polymorphism may influence response to treatment with tyrosine kinase inhibitors in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171590.RAUlmLojG3naeDPoWnR_JZbI2Bkr3XvN6Eac1v4qP3gq8130_provenance.
- assertion description "[EGFR intron 1 polymorphism may influence response to treatment with tyrosine kinase inhibitors in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_assertion description "[EGFR intron 1 polymorphism may influence response to treatment with tyrosine kinase inhibitors in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_provenance.